Form 4: Astera Labs Director Michael Hurlston Acquires Shares in Directed Share Program
SEC Form 4 Filing
Director Michael Hurlston reports the acquisition of 21,747 shares of Astera Labs, Inc. common stock at $36 per share through a directed share program related to the company's IPO.
Summary
- On March 22, 2024, Michael Hurlston, a director of Astera Labs, Inc. (ALAB), acquired 21,747 shares of common stock.
- The shares were purchased at a price of $36 per share.
- The acquisition was made through a directed share program in connection with Astera Labs' initial public offering (IPO).
- Following the transaction, Hurlston directly owns 121,747 shares of Astera Labs.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares at the IPO price indicates confidence, but it's a standard practice.
Positives
- A director's participation in a directed share program signals confidence in the company's prospects following its IPO.
Industry Context
Directed share programs are often offered to company insiders and related parties during an IPO to align their interests with the long-term success of the company. This purchase by a director is a fairly standard practice.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholder sentiment as it demonstrates insider confidence.
Key Dates
| Date | Description |
|---|---|
| 03/22/2024 | Date of transaction: Michael Hurlston acquired 21,747 shares of Astera Labs common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.